relapsing chronic myelogenous leukemia

Known as: CML, relapsed, CML, relapsing, relapsed chronic myelocytic leukemia 
The reemergence of chronic myelogenous leukemia after a period of remission.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-2017
0102019642017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) induced by the BCR-ABL oncogene is believed to be developed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Dasatinib is an inhibitor of BCR-ABL and SRC-family kinases for patients with imatinib-resistant or -intolerant chronic… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia (CML-AP) have very limited… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Although imatinib induces marked responses in patients with chronic myeloid leukemia (CML), resistance is increasingly… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The prognosis for patients with chronic myeloid leukemia (CML) in myeloid blast crisis (MBC) or lymphoid blast crisis (LBC… (More)
  • table 1
  • table 4
  • table 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Advanced glycation endproduct (AGE) levels are elevated in renal failure patients and may contribute to the excessive… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The efficacy and toxicity of donor leukocyte infusions (DLI) after unrelated donor bone marrow transplantation (BMT) is largely… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The effectiveness of donor-lymphocyte infusion (DLI) for treatment of relapsed chronic myelogenous leukemia (CML) after… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Eight patients who had hematologic relapse of chronic myelogenous leukemia (CML) after undergoing allogeneic bone marrow… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Three patients with hematologic relapse after bone marrow transplantation for chronic myelogenous leukemia were treated with… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?